UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047182
Receipt number R000053820
Scientific Title Performance verification test of a software medical device with artificial intelligence to detect signs of paroxysmal atrial fibrillation
Date of disclosure of the study information 2022/03/16
Last modified on 2023/03/16 10:28:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Performance verification test of a software medical device with artificial intelligence to detect signs of paroxysmal atrial fibrillation

Acronym

Performance verification test of a software medical device with artificial intelligence to detect signs of paroxysmal atrial fibrillation

Scientific Title

Performance verification test of a software medical device with artificial intelligence to detect signs of paroxysmal atrial fibrillation

Scientific Title:Acronym

Performance verification test of a software medical device with artificial intelligence to detect signs of paroxysmal atrial fibrillation

Region

Japan


Condition

Condition

paroxysmal atrial fibrillation

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the performance of an automatic ECG analysis system using artificial intelligence.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sensitivity and specificity for the results of sign detection

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Artificial Intelligence Enabled EDC Analysis System

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Paroxysmal atrial fibrillation group
1.Persons who have given written consent
2.Persons diagnosed as paroxysmal atrial fibrillation
3.Persons expected to have an atrial fibrillation attack more frequency than once a week

Control group
1.Persons with confirmed sinus rhythm

Key exclusion criteria

Paroxysmal atrial fibrillation group
1.Persons diagnosed with persistent or permanent atrial fibrillation
2.Persons undergoing treatment(catheter ablation, open heart surgery, pacemaker implantation, percutaneous atrial septal defect closure)

Control group
1.Persons who have a history of diagnosis of paroxysmal atrial fibrillation, persistent atrial fibrillation, or permanent atrial fibrillation
2.Persons undergoing treatment(catheter ablation, open heart surgery, pacemaker implantation, percutaneous atrial septal defect closure)

Target sample size

45


Research contact person

Name of lead principal investigator

1st name Yuichi
Middle name
Last name Tamura

Organization

International University of Health and Welfare, Shool of Medicine

Division name

Department of Cardiology

Zip code

108-8329

Address

1-4-3 Mita, Minato-ku Tokyo

TEL

0334518175

Email

u1@iuhw.ac.jp


Public contact

Name of contact person

1st name Chieko
Middle name
Last name Akiyama

Organization

International University of Health and Welfare, Mita Hospital

Division name

Clinical Trial Management Office

Zip code

108-8329

Address

1-4-3 Mita, Minato-ku Tokyo

TEL

0334518175

Homepage URL


Email

minamikawa@iuhw.ac.jp


Sponsor or person

Institute

IUHW

Institute

Department

Personal name



Funding Source

Organization

AMED

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

International University of Health and Welfare

Address

1-24-1,minami-aoyama,minato-ku,Tokyo

Tel

0476-35-5607

Email

iuhw-irb@iuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 05 Month 10 Day

Date of IRB

2021 Year 05 Month 27 Day

Anticipated trial start date

2021 Year 09 Month 17 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 03 Month 16 Day

Last modified on

2023 Year 03 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053820